Acute Promyelocytic Leukemia — Trials

Acute Promyelocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02899169	Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)(APL16)	unknown	Phase 3	110	First Affiliated Hospital Xi'an Jiaotong UniversityOTHER	1	Sep 8, 2021	clinicaltrials
NCT04175587	Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL(RIF)	unknown	Phase 3	109	Peking University People's HospitalOTHER